August 14th 2021
“We are fortunate now to live in an era where we have nine new drugs approved (for AML) just in the last five years,” says an expert from The University of Texas MD Anderson Cancer Center.
August 10th 2021
Treatment for acute lymphoblastic leukemia can be long and difficult at times, but the end goal is curing the disease.
August 9th 2021
Outcomes in patients with CLL continue to improve with the emergence of targeted drugs and immunotherapy.
August 4th 2021
How are myelodysplastic syndromes diagnosed and staged? What causes them? An expert from Moffit Cancer Center offers insight.
August 3rd 2021
View the full CURE Educated Patient Leukemia Summit on demand.
Welireg Plus Lenvima Has ‘Promising Antitumor Activity’ in Kidney Cancer Subset
Pre- and Post-Surgical Keytruda Boosts Outcomes in Early NSCLC
An App Improved Anxiety, Depression Symptoms in Patients With Cancer
Imjudo-Imfinzi Regimen Improves Survival With Manageable Side Effects in Liver Cancer Subset